DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

Fifty 410 vs Yucca Health: November 2026 prices compared

As of November 20, 2026, from each program’s own page: on compounded tirzepatide, month to month and all-in, Fifty 410 charges $199 per 28-day cycle and Yucca Health $139 a month: $2,587 against $1,668 for a year, so Yucca Health costs $919 less over a year.

Released · Last reviewed · how we verify

On compounded semaglutide, month to month and all-in, Fifty 410 charges $199 per 28-day cycle and Yucca Health $89 a month: $2,587 against $1,068 for a year, so Yucca Health costs $1,519 less over a year.

Fifty 410 and Yucca Health, measure by measure

Fifty 410 and Yucca Health side by side, from each program’s own page read November 20, 2026 (all-in: medication plus any required recurring fee, before tax)
MeasureFifty 410Yucca Health
Tirzepatide, month to month$199 (per 28-day cycle)$139 (per month)
Tirzepatide, lowest printed$149.50 (8-week program at $299, not in all states)$119 (12-month plan, $1,428 upfront)
Semaglutide, month to month$199 (per 28-day cycle)$89 (per month)
Semaglutide, lowest printed$199 (4-week program)$69 (12-month plan, $828 upfront)
Dose pricingpriced by dose or not statedsame price at every dose
Membership or program feenonenone
Computed score23.5 of 40 (position 8 of 27)34.7 of 40 (position 2 of 27)
FDA warning letters721481 (2026-02-20)none listed
November 20 readfirst-party read, changedfirst-party read, changed

Strengths and limitations: which fits whom

Fifty 410 bills every 28 days, which adds a 13th charge to the year. Yucca Health prints one price at every dose with no membership, so a dose increase does not change the bill. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.

What changed since August

The first version of this comparison used captures from August 5–10, 2026. The November 20 re-read replaces them; the August figures are kept below as history, dated.

What changed since the August 2026 capture (maintenance-dose all-in figure then; month-to-month all-in figure read November 20, 2026)
ProgramMedicationAugust 5–10, 2026November 20, 2026
Fifty 410tirzepatide—$199
Fifty 410semaglutide—$199
Yucca Healthtirzepatide—$139
Yucca Healthsemaglutide—$89

Regulatory record

FDA’s warning-letter index lists warning letter 721481 (dated February 20, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to Fifty 410; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Check Fifty 410’s current prices ↗
Check Yucca Health’s current prices ↗

Frequently asked

Which is cheaper, Fifty 410 or Yucca Health?

On compounded tirzepatide, month to month and all-in, Fifty 410 charges $199 per 28-day cycle and Yucca Health $139 a month: $2,587 against $1,668 for a year, so Yucca Health costs $919 less over a year. On compounded semaglutide, month to month and all-in, Fifty 410 charges $199 per 28-day cycle and Yucca Health $89 a month: $2,587 against $1,068 for a year, so Yucca Health costs $1,519 less over a year.

Do Fifty 410 and Yucca Health charge a membership fee?

Fifty 410: no membership fee; Yucca Health: no membership fee. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.

Are Fifty 410 and Yucca Health medications FDA-approved?

Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.

Fifty 410 recordYucca Health recordYucca Health alternativesAll head-to-headsRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.